About Spex Capital
Spex Capital is a digital health and med-tech investment management firm specialised in advancing disruptive early-stage ventures to deliver breakthroughs in healthcare systems globally. We identify, support, and invest in early-stage digital health companies, to commercialise and scale within the NHS and other healthcare delivery systems. Founded in 2021 by Claudio D'Angelo, we are headquartered in London and benefit from a special NHS partnership, via DH.L & MedCity and a global healthcare ecosystem via partnerships and relationships with embassies, chambers of commerce, trade bodies, accelerators & incubators, universities, hospitals, payors and healthcare systems across all continents to source the highest caliber technologies worldwide.